Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Top Cited Papers
Open Access
- 1 January 2015
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 148 (1), 77-87.e2
- https://doi.org/10.1053/j.gastro.2014.09.038
Abstract
No abstract availableFunding Information
- National Cancer Institute (KL2TR000421, K07CA172298, R01CA118699, R01CA107333, K05CA142885, R01CA076366, U01CA74794)
- National Center for Advancing Translational Sciences (KL2TR000421, K07CA172298, R01CA118699, R01CA107333, K05CA142885, R01CA076366, U01CA74794)
- National Institutes of Health (KL2TR000421, K07CA172298, R01CA118699, R01CA107333, K05CA142885, R01CA076366, U01CA74794)
This publication has 48 references indexed in Scilit:
- Genome-scale analysis of aberrant DNA methylation in colorectal cancerGenome Research, 2011
- 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal CancerGastroenterology, 2011
- Multiple imputation by chained equations: what is it and how does it work?International Journal of Methods in Psychiatric Research, 2011
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology, 2010
- Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancerBritish Journal of Surgery, 2009
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerGut, 2008
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Mutations of the BRAF gene in human cancerNature, 2002
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001